# multiBIND

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/multibind

- Industry: Biotechnology
- Headquarters: Cologne, Germany
- Website: www.multibind.de
- Total disclosed funding: $0.8M
- Latest round: Seed (Oct 4, 2006)
- Investors on record: 2

## About

multiBIND biotec GmbH develops advanced decontamination solutions, specializing in biological agents that effectively eliminate nucleic acid contamination across various sectors, including healthcare and industrial applications.Founded in 2005 in Cologne, Germany, multiBIND biotec GmbH focuses on innovative decontamination technologies. The company raised EUR 0.63 mn in a Seed round in July 2008, co-led by AppliChem GmbH and High-Tech Gruenderfonds. CEO Thomas Lisowsky leads the firm, which has completed two significant deals in its history.multiBIND biotec GmbH specializes in innovative decontamination and disinfection solutions, with their flagship product, bioDECONT, being a new generation of biological decontamination agents. bioDECONT is designed to treat surfaces and equipment in various sectors including laboratories, industrial environments, and healthcare facilities. This product operates effectively as a single agent for managing unwanted nucleic acid contamination and mitigating risks associated with Horizontal Gene Transfer. Their client base includes manufacturers and distribution companies seeking to enhance their products' value and access new markets through licensing opportunities. The geographical markets served by multiBIND span Europe, with specific emphasis on areas facing stringent bio-safety standards in food production and clinical settings.multiBIND biotec GmbH generated revenue of EUR 626,094.80 in 2021, with an EBITDA of EUR 196,392.50. The primary revenue source stems from partnerships and licensing agreements related to their bioDECONT product. Clients, including manufacturers and industrial companies, engage with multiBIND to license bioDECONT, enabling them to incorporate the agent into their own products. The company’s service offerings also include tailored analyses of water quality and other aqueous solutions, further diversifying their revenue streams.Looking ahead, multiBIND biotec GmbH aims to expand its product lineup with new decontamination solutions targeted for launch by 2024. The company plans to penetrate additional European markets, particularly focusing on regions with strict bio-safety regulations. The recent Seed funding of EUR 0.63 mn will be utilized to support these growth initiatives, enhancing product development and market entry strategies. In July 2008, multiBIND raised funding co-led by Sirius Seedfonds Dusseldorf and Rheinland Venture Capital.

## Funding rounds

- Seed, Oct 4, 2006, $0.8M — High-Tech Gruenderfonds, AppliChem GmbH

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- AppliChem GmbH — Seed